2012 MPCC Symposium
15TH ANNUAL MASSACHUSETTS PROSTATE CANCER SYMPOSIUM (May 2012)
Content recorded May 18th, 2012
Allen L. Snyder III
Chairman, Massachusetts Prostate Cancer Coalition
C. Hall Swaim, Esq.
President, Massachusetts Prostate Cancer Coalition
Treater to Target: A Urologist’s Perspective of Prostate Cancer
Prostate cancer is common and the issues associated with diagnosis and treatment controversial. A personal journey through these issues from both sides of the process — treater and target — illustrates the changes and challenges of each disease state.
Paul F. Schellhammer, MD, Professor of Urology, Eastern Virginia Medical School
Shared Decision-Making for Prostate Cancer Screening
Despite the publication of two large clinical trials of PSA screening for prostate cancer, controversy continues about the balance of its benefits and harms. Shared decision- making with individual patients has been suggested as one way to resolve the controversy, “one man at a time.” This session will review how clinicians help patients make a decision about prostate cancer screening that’s right for them.
Michael Barry, MD, President — Foundation for Informed Medical Decision Making
Prostate Cancer Survivorship: What Every Man Should Know
This session describes the potential side effects of androgen deprivation therapy, including osteoporosis, fractures, muscle loss, fat accumulation, diabetes, and cardiovascular disease. The session also describes methods to monitor potential adverse effects as well as effective strategies to minimize or prevent the unintended side effects of treatment.
Alicia K. Morgans, MD, Massachusetts General Hospital
No Easy Answer for Prostate Questions: Help is on the Way from Two Websites
The closing keynote discusses and demonstrates the resources available on two new websites, including harvardprostateknowledge.org, that provide new and user-friendly ways to help with decision making.
Marc B. Garnick, MD, Beth Israel Deaconess Medical Center